Home › Prostate Cancer › North Carolina › Concord
Prostate Cancer clinical trials in Concord, NC
5 studies for Prostate Cancer are looking for participants at sites in and around Concord (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
RecruitingPhase 2
- Salisbury W.G. (Bill) Hefner VA Medical Center, Salisbury, NC, Salisbury · 19 mi away
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
RecruitingPhase 3
- Atrium Health Cabarrus/LCI-Concord, Concord
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
RecruitingPhase 2
- W.G. Bill Hefner Medical Center, Salisbury · 19 mi away
Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer
RecruitingPhase 2
- W.G. Bill Hefner VA Medical Center, Salisbury · 19 mi away
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
RecruitingPhase 3
- Atrium Health Cabarrus/LCI-Concord, Concord
- Atrium Health Stanly/LCI-Albemarle, Albemarle · 22 mi away
About Prostate Cancer
Prostate cancer is one of the most common types of cancer among American men. The risk goes up as men age. Learn about symptoms, tests, and treatment.
More about Prostate Cancer on MedlinePlus
Prostate Cancer trials in other cities
- New York City, NY103 studies
- Houston, TX76 studies
- Los Angeles, CA61 studies
- Boston, MA59 studies
- St. Louis, MO46 studies
- Chicago, IL45 studies
- San Francisco, CA45 studies
- Philadelphia, PA44 studies
- Baltimore, MD43 studies
- Nashville, TN43 studies
- Seattle, WA42 studies
- Washington, DC38 studies
Other studies in Concord
- Breast Cancer5 studies
- Cancer (all types)3 studies
- Colorectal Cancer3 studies
- Obesity3 studies
- Blood Clots3 studies
- Lung Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.